An Alternative Application of Sodium Nitroprusside to Overcome Perioperative Spasm of the Internal Thoracic Artery

Objective: The internal thoracic artery (ITA) is currently the preferred conduit for myocardial revascularization; however, perioperative vasospasm of the internal thoracic artery may cause morbidity. Pedicle preparation and pharmacological vasodilatory treatment vary greatly. This clinical study was performed in order to define the effectiveness of two different applications of sodium nitroprusside as vasodilating agent. Methods: Eighty-six (86) consecutive patients whose left internal thoracic artery was mobilized only by one surgeon for elective coronary artery bypass graft operations were randomly divided into two groups. The internal thoracic artery was allowed to bleed freely, and the flow was determined (flow 1). In group I (n = 42) 3mg sodium nitroprusside in 10 ml of 5% dextrose solution was sprayed with pressure on the pedicle with a thin 25 gauge needle. In group II (n = 44) half of the solution was sprayed in the same manner, and the other half of the solution was injected into the pedicle in the periarterial tissue along the length of the pedicle. Free flows of the internal thoracic artery were registered before cardiopulmonary bypass (flow 2) and also just prior to performing internal thoracic artery anastomosis to the left anterior descending artery (flow 3). With each measurement hemodynamic parameters and the time between measurements were recorded. Results: No statistically significant differences were found between the groups in respect to sex ratio, age, body surface area, heart rate 1 and 2, mean arterial pressure 1 and 3. There was no significant difference in the initial flow among groups. Significant differences were noted in the second flow measurement (P < 0.05) and in the third flow measurement (P < 0.01) between two groups. For each group there was a significant increase in flow from flow 1 to flow 2 and from flow 2 to flow 3 (P < 0.02). Conclusion: Sodium nitroprusside injection to the pedicle provides a better flow than simple spraying of the same agent.

[1]  A. Cohen,et al.  Effect of topical vasodilators on internal mammary arteries. , 1995, The Annals of thoracic surgery.

[2]  H. Tatar,et al.  Use of topical sodium nitroprusside to relieve perioperative spasm of the internal mammary artery: a word of caution. , 1994, The Journal of thoracic and cardiovascular surgery.

[3]  G. He Contractility of the human internal mammary artery at the distal section increases toward the end. Emphasis on not using the end of the internal mammary artery for grafting. , 1993, The Journal of thoracic and cardiovascular surgery.

[4]  F. Smedts,et al.  Histological study of the internal mammary artery with emphasis on its suitability as a coronary artery bypass graft. , 1993, The Annals of thoracic surgery.

[5]  G. Angelini,et al.  Overcoming perioperative spasm of the internal mammary artery: which is the best vasodilator? , 1992, The Journal of thoracic and cardiovascular surgery.

[6]  K. Kondo,et al.  Pharmacological response of internal mammary artery and gastroepiploic artery. , 1990, The Annals of thoracic surgery.

[7]  G. Angelini,et al.  Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. , 1990, The Journal of thoracic and cardiovascular surgery.

[8]  N. Mills,et al.  Preparation of the internal mammary artery graft. Which is the best method? , 1989, The Journal of thoracic and cardiovascular surgery.

[9]  L. Noyez "Inadequate Flow After Internal Mammary-Coronary Artery Anastomoses". , 1988, The Thoracic and cardiovascular surgeon.

[10]  G E Reed,et al.  Early postoperative spasm in left internal mammary artery bypass grafts. , 1987, The Annals of thoracic surgery.

[11]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[12]  J. Okies,et al.  The left internal mammary artery: the graft of choice. , 1984, Circulation.